malondialdehyde has been researched along with docetaxel anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fong, DW; Huang, W; Wong, Y; Yang, Z; Yin, L | 1 |
| Ates, H; Aydin, S; Cehreli, R; Cengiz, H; Harmanci, D; Kemanli, P; Kocdor, H; Kocdor, MA; Soyarat, F | 1 |
2 other study(ies) available for malondialdehyde and docetaxel anhydrous
| Article | Year |
|---|---|
Liposomes modulate docetaxel-induced lipid oxidization and membrane damage in human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Docetaxel; Hep G2 Cells; Humans; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipids; Liposomes; Liver Neoplasms; Malondialdehyde; Membranes; Oxidation-Reduction; Superoxide Dismutase; Taxoids | 2009 |
Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Inhibitory Concentration 50; Lung Neoplasms; Malondialdehyde; Oxidative Stress; Taxoids; Tumor Suppressor Protein p53; Zinc | 2015 |